#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxofibrosarcoma Spina bifida Neutropenia Idiopathic pulmonary fibrosis Peripheral primitive neuroectodermal tumour of soft tissue Crohn's disease Infective uveitis Cystic fibrosis lung Retinoblastoma Plasma cell myeloma recurrent Cognitive disorder Anaplastic large cell lymphoma T- and null-cell types Thermal burn Proteus syndrome Mantle cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Idiopathic pulmonary fibrosis Mantle cell lymphoma Encephalitis autoimmune – Basic Information Small intestine leiomyosarcoma Choroid melanoma Myelodysplastic syndrome with excess blasts – Trials in Disease Glycogen storage disease type I – Trials in Disease Sjogren’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Stiripentol Tamoxifen ALENDRONATE SODIUM TRIHYDRATE Dinoprostone Vib1116 Terlipressin Saxagliptin Imetelstat Sodium D5-Ethyl-Beta-D-Glucuronide Hct116-B Pyridoxine Cangrelor Tetrasodium Olive Oil, Refined ASP3082 Niflumic Acid Aptamer-4Ft For-6219 Pramlintide Acetate RO7288817 DROSPIRENONE More therapies…

    Learn about Your Condition

    Small intestine leiomyosarcoma Post cardiac arrest syndrome Biliary adenoma Neonatal hyperglycaemia B-cell lymphoma recurrent Insomnia Ovarian cancer recurrent Mitral valve incompetence Oesophageal carcinoma Polyneuropathy Knee arthroplasty Epstein-Barr virus infection Macular oedema Rectal adenocarcinoma Pulmonary hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Fosfomycin versus drug combination for oral step‑down treatment of febrile urinary tract infections caused by E. coli in men

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Escherichia urinary tract infection
    Investigated Drugs:
    • Fosfomycin
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    France

  • Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Pegcetacoplan
    France Germany Italy Poland Portugal Slovakia +1

  • Evaluation of PIFLUFOLASTAT (18F) PET/CT for monitoring prostate cancer recurrence in patients with favourable intermediate‑risk localized disease after focal HIFU

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    France

  • Effect of serenoa repens on chronic prostate inflammation in men with benign prostatic hyperplasia: a phase III randomized study

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Italy

  • BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • BMS-986365
    Germany

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    • Pyelonephritis acute
    • Urinary tract infection
    Investigated Drugs:
    • Ciprofloxacin
    Belgium
Previous Page
1 … 11 12 13 14 15 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!